From major journals, first or last author from the Institute for Cancer Research
Moosavi SH, Kryeziu K, Eilertsen IA, Nunes L, Hektoen M, Niederdorfer B, Reims HM, Syversveen T, Grut H, Dueland S, Line PD, Lothe RA, Sveen A(2025) Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer Br J Surg, 112(4) DOI 10.1093/bjs/znaf072, PubMed 40235343
Axcrona K, Axcrona U, Skotheim RI(2025) Re: Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-invisible Prostate Cancers: A Matched-pair Analysis Eur Urol(in press) DOI 10.1016/j.eururo.2025.04.002, PubMed 40222874
Bergholtz H, Norum JH, Lien TG, Skrede ML, Garred Ø, Sørlie T(2025) B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses Breast Cancer Res, 27(1), 44 DOI 10.1186/s13058-025-01990-2, PubMed 40119362
Dechow A, Timonen S, Ianevski A, Jiang Q, Wahnschaffe L, Peng Y, Jungherz D, Becker K, Neubauer HA, Schönefeldt S, de Araujo E, Gunning P, Fleck R, Schrader A, Hallek M, Pflug N, Moriggl R, Aittokallio T, Mustjoki S, Braun T, Herling M(2025) Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia Leukemia(in press) DOI 10.1038/s41375-025-02577-8, PubMed 40234614
Axcrona K, Axcrona U, Skotheim RI(2025) Re: Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging-invisible Prostate Cancers: A Matched-pair Analysis Eur Urol(in press) DOI 10.1016/j.eururo.2025.04.002, PubMed 40222874
Nygrén P, Bouhlal J, Jokinen E, Forstén S, Laajala E, Dias D, Adnan-Awad S, Ianevski A, Klievink J, Lähteenmäki H, Kuusanmäki H, Myllymäki M, Kasanen T, Saeed K, Lee DA, Hjorth-Hansen H, Aittokallio T, Dufva O, Mustjoki S(2025) High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia Blood, 145(15), 1670-1686 DOI 10.1182/blood.2024025286, PubMed 39792962
